MediciNova, Inc., a biopharmaceutical company listed on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of ...
Gedeptin is a non-replicating adenoviral vector delivering the E. coli purine nucleoside phosphorylase (PNP) gene directly into tumor tissue. Following intratumoral injection, patients receive ...
An update from CSPC Pharmaceutical Group ( ($HK:1093) ) is now available. CSPC Pharmaceutical Group Limited has announced that its GLP-1/GIP ...
TipRanks on MSN
Candel Therapeutics hosts virtual R&D day on immunotherapy
An announcement from Candel Therapeutics ( ($CADL) ) is now available. On December 5, 2025, Candel Therapeutics will host a virtual R&D Day to ...
Get the latest on Vera Therapeutics, Inc., FDA progress for atacicept, and IgA nephropathy drug competition. Click to what to ...
Continuous variable modeling such as the Hodgkin lymphoma international prognostic index (A-HIPI) improves prognostic ...
Syndax Pharmaceuticals, Inc. ( SNDX) The 67th American Society of Hematology ( ASH) Annual Meeting December 8, 2025 7:00 AM EST ...
First real-world evidence for a menin inhibitor shows 77% ORR (10/13), 31% (4/13) CR/CRh, 75% (9/12) MRD negativity, and favorable tolerability ...
Key factors driving this growth include the rising prevalence of cancer, continuous advancements in CAR T-cell technologies, a ...
Clinical Trials Market Insights: Industry Opportunities, Drivers, Outlook and Trends Research Report
The global clinical trials market is anticipated to grow at a CAGR of 6-7% from 2024 to 2029. This growth is driven by the ...
Digit health technologies (DHT) are a key aspect of U.S. Health & Human Services (HHS) Secretary Robert F. Kennedy Jr.’s Make America Healthy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback